John Gustofson

Managing Director · AbbVie Ventures

Decision makerActive

Email

Verified, deliverable email

Managing Director at AbbVie Ventures

Stages: Series A, Seed
Cheque size: €92k–€1.4M
Freshness: Verified today

Notable investments

Ten63 TherapeuticsSeries Unknown · $16M · 2026
Leal TherapeuticsSeries A · $30M · 2025
Stylus MedicineSeries A · $85M · 2025
Caraway TherapeuticsSeries A · $23M · 2018
RibometrixSeries A · $30M · 2018

Frequently co-invests with

Mike DialHatteras Venture Partners2×Arvind GuptaMayfield FundClay ThorpHatteras Venture PartnersDamien PettyMorpheus VenturesHakan Goker (M Ventures (Merck))Jack KenneySV Health InvestorsPo BronsonSOSVReza HalseRA Capital

Similar investors

Birgitte Gangmark VillmoInvestor, Investinor

Fred TuomiVenture Partner, RET Ventures

Alexandre BartoliniManaging Director, Inveready Technology Investment Group

Axel Sven SpringerAngel, Independent

Ari KorhonenPartner, True Global Ventures

Phyllis WhiteleyVenture Partner, Wildcat Venture Partners

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you John Gustofson? Request removal of this listing.